Drug Type ASO |
Synonyms- |
Target |
Mechanism FMRP inhibitors(FMRP translational regulator 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fragile X Syndrome | Preclinical | US | 25 Jun 2024 | |
Fragile X Syndrome | Preclinical | US | QurAlis Corp.Startup | 25 Jun 2024 |